Avenue Therapeutics, Inc.
ATXI
$0.7727
-$0.0003-0.04%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.08M | -2.69M | -4.34M | 640.00K | 526.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 316.00K | 277.00K | 880.00K | -2.05M | -1.02M |
| Change in Net Operating Assets | -129.00K | 162.00K | 340.00K | -911.00K | -391.00K |
| Cash from Operations | -2.89M | -2.25M | -3.12M | -2.32M | -889.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -1.00M |
| Cash from Investing | -- | -- | -- | 0.00 | -1.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 567.00K | 4.74M | 4.97M | 3.88M | 550.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -765.00K | -442.00K | 71.00K | -71.00K |
| Cash from Financing | 567.00K | 3.98M | 4.53M | 3.95M | 479.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.32M | 1.73M | 1.41M | 1.62M | -1.41M |
